Regions
MetroPCS reaffirms commitment to combination with T-Mobile USA
MetroPCS reaffirms commitment to combination with T-Mobile USA MetroPCS Communications, Inc. (NYSE: PCS) today reaffirmed its commitment to the proposed combination of MetroPCS and T-Mobile USA announced October 3, 2012 in response to a letter from P.
Investor to vote against MetroPCS/T-Mobile USA deal
Shareholders holding about 7.5 million shares of MetroPCS Communications said intends to vote against the company's proposed merger
Deals of The Day — Mergers and Acquisitions
The following bids, mergers, acquisitions and disposals were reported on Wednesday. The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Wednesday: Biogen Idec is to take full ownership of blockbuster multiple sclerosis drug Tysabri after agreeing to pay Irish partner Elan $3.
Biogen's Purchase of Multiple Sclerosis Drug Ends Rocky Partnership with Elan
Biogen Idec agreement to buy Elan Corp's interest in the multiple sclerosis drug Tysabri gives Biogen full control of a product that is poised for further growth and ends a long partnership that has often been contentious.




